Author
Ieva Drulyte
Thermo Fisher Scientific (Netherlands)ORCID 0000-0003-1117-7699Unclaimed ORCID profile · follow to get notified of new preprints
Biology Disciplines
Click to filter author papersSignature Assays, Organisms & Methods
Click to filter · or open tagActivity by Year
2024-2026 · peak 3/yrCo-Author Collaboration Network
10 top collaborators · 18 mutual co-author links7 papers
Recent·Most cited
- MicrobiologybioRxivPreprint
Spike and host glycan determinants of HKU1 airway tropism
Robert Creutznacher, Louisa E. Wallace, Oliver J. Debski-Antoniak…·Raoul J. de Groot
This study identifies spike and host glycan determinants of HKU1 airway tropism by showing preferential binding to 9-O-acetylated 2,8-linked disialosides and structural insights into ligand recognition.
DOI 10.64898/2026.08.05.741156 - BiochemistryScientific ReportsPeer-reviewed
Discovery of Membrane Channel Modulators via DNA-Encoded Library Screening Using Native-Like Membrane Protein Nanoparticles
Francesco V. Reddavide, Trine Lisberg Toft‐Bertelsen, Ieva Drulyte…·Robin Löving
This paper develops a method to discover PANX1 modulators using DNA-encoded library screening with stabilized membrane protein nanoparticles and validates hits through biophysical and electrophysiological assays.
DOI 10.1038/s41598-026-58370-9 - MicrobiologybioRxivPreprint
The gH/gL/gO Complex of Elephant Endotheliotropic Herpesvirus 1A Functions as a Receptor Binding Complex
Oliver J. Debski-Antoniak, Lukas Ermers, Jasper Kroes…·Tabitha E. Hoornweg
This paper determines the structure of the EEHV1A gH/gL/gO complex and shows it functions as the receptor-binding complex for EEHV1A.
DOI 10.64898/2025.12.03.692000 - Pharmacology & ToxicologybioRxivPreprint
Investigation of anti-SARS CoV-2 multimeric bicyclic peptide inhibitors in a range of pre-clinical therapeutic settings
Maximilian A. J. Harman, Katherine U. Gaynor, Guido Papa…·Michael J. Skynner
This paper evaluates the efficacy of multimeric bicyclic peptides as antiviral agents in preclinical SARS-CoV-2 models, showing significant reduction in viral burden across multiple therapeutic settings.
DOI 10.1101/2025.10.03.680220 - MicrobiologyJournal of NanobiotechnologyPeer-reviewed
A Spike Trimer Dimer-Inducing Nanobody with Anti-Sarbecovirus Activity
Iris C. Swart, Oliver J. Debski-Antoniak, Aneta Zegar…·Sabrina Oliveira
This paper describes a nanobody, 7F, that neutralizes SARS-CoV-2 and cross-neutralizes SARS-CoV and SARS-like CoV pseudoviruses by inducing spike trimer dimers and shows therapeutic potential in 3D tissue cultures.
5 citations - BioinformaticsbioRxivPreprint
Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations
Frédéric A. Dreyer, Constantin Schneider, Aleksandr Kovaltsuk…·Charlotte Mary Deane
This paper presents a computational pipeline for designing therapeutic antibodies using AI and physics-based methods, showing improved binding and developability across SARS-CoV-2 variants.